{"name":"Esperance Pharmaceuticals","permalink":"esperance-pharmaceuticals","crunchbase_url":"http://www.crunchbase.com/company/esperance-pharmaceuticals","homepage_url":"http://www.esperancepharma.com","blog_url":"","blog_feed_url":"","twitter_username":"","category_code":"biotech","number_of_employees":null,"founded_year":null,"founded_month":null,"founded_day":null,"deadpooled_year":null,"deadpooled_month":null,"deadpooled_day":null,"deadpooled_url":null,"tag_list":"","alias_list":"","email_address":"admin@esperancepharma.com","phone_number":"225-615-8944","description":"","created_at":"Thu Jun 02 03:18:35 UTC 2011","updated_at":"Thu Jun 02 03:26:10 UTC 2011","overview":"<p>Esperance Pharmaceuticals is developing a new class of targeted anticancer drugs that selectively kill cancer cells without harming normal cells. Targeting occurs through binding to specific receptors on the cell&#8217;s surface. The drugs kill even those cells known to be resistant to chemotherapeutic drugs.</p>","image":{"available_sizes":[[[150,30],"assets/images/resized/0013/7401/137401v1-max-150x150.jpg"],[[250,50],"assets/images/resized/0013/7401/137401v1-max-250x250.jpg"],[[419,84],"assets/images/resized/0013/7401/137401v1-max-450x450.jpg"]],"attribution":null},"products":[],"relationships":[],"competitions":[],"providerships":[],"total_money_raised":"$7.5M","funding_rounds":[{"round_code":"b","source_url":"http://money.msn.com/business-news/article.aspx?feed=PR&Date=20110601&ID=13713866&topic=TOPIC_FINANCING&isub=1","source_description":"Esperance Pharmaceuticals Completes $7.5 Million Series B Financing","raised_amount":7500000,"raised_currency_code":"USD","funded_year":2011,"funded_month":6,"funded_day":1,"investments":[{"company":null,"financial_org":{"name":"Louisiana Fund I","permalink":"louisiana-fund-i","image":null},"person":null},{"company":null,"financial_org":{"name":"Themelios Ventures","permalink":"themelios-ventures","image":null},"person":null},{"company":null,"financial_org":{"name":"Advantage Capital Partners","permalink":"advantage-capital-partners","image":{"available_sizes":[[[150,105],"assets/images/resized/0002/1156/21156v1-max-150x150.jpg"],[[176,124],"assets/images/resized/0002/1156/21156v1-max-250x250.jpg"],[[176,124],"assets/images/resized/0002/1156/21156v1-max-450x450.jpg"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"Louisiana Technology Innovation Fund","permalink":"louisiana-technology-innovation-fund","image":null},"person":null}]}],"investments":[],"acquisition":null,"acquisitions":[],"offices":[{"description":"","address1":"Louisiana Emerging Technology Center","address2":"340 East Parker Blvd.","zip_code":"70803","city":"Baton Rouge","state_code":"LA","country_code":"USA","latitude":null,"longitude":null}],"milestones":[],"ipo":null,"video_embeds":[],"screenshots":[],"external_links":[]}